News

For more detail about the Department's research themes, clinical trials, research leaders and projects, see the Research and Staff pages.

Follow the Department of Infectious Diseases on Twitter

See all Central Clinical School news, including Infectious Disease highlights here.

A monthly blog profiling CCS news highlights can be subscribed to, at: Monash CCS Blog.


2019

  

Congratulations to Dr Kelly Wyres and Dr Nenad Macesic who received Emerging Leader grants from the NHMRC Investigator grants scheme.

Dr Kelly Wyres will develop a clone-specific risk framework for Klebsiella pneumoniae transmission and AMR

Dr Macesic will investigate how to integrate genomic and artificial intelligence approaches to combat antimicrobial resistance

 

Dr Joseph Doyle from the Department of Infectious Diseases has received a $1.459 million Clinical Trials and Cohort Studies grant from the National Health and Medical Research Council to conduct a paradigm-changing trial assessing the clinical and cost-effectiveness of a same-visit HCV testing and treatment model of care for PWID.

The QuickStart Study will use a cluster randomised controlled trial design to evaluate the impact of rapid testing and treatment provision on hepatitis cure. The hypothesis is that a same-day test and treatment model of care will significantly enhance hepatitis cure among PWID, and be cost-effective in real-world settings.

“Surveillance data and modelling shows us that health-care providers are not testing and re-testing often enough to engage people in care. This makes it harder and more expensive to reach our HCV elimination targets. It also leaves many people living with a curable infection because they are not linked to health care,” Dr Doyle said.

“A same-visit service would simplify care, lead to more people starting treatment, and more people will be cured. It may also be highly cost-effective and help implement Australia’s national hepatitis C strategy,” he said.

 Professor Anton Peleg. successfully secures NHMRC funding to understand how a superbug that causes severe infections in hospitalised patients worldwide and is known to be resistant to almost all available antibiotics, causes disease. His team will use this information to guide the development of a new type of therapy to treat this severe infection.

Congratulations Professor Jenny Hoy, elected Fellow of the Australian Academy of Health and Medical Sciences (AAHMS).

Professor Hoy has made significant contributions to the HIV research effort nationally and internationally. Her main research interest is in the evaluation of the causes of co-morbidity and mortality in people living with HIV infection and the effect of Antiretroviral Therapy.

 Prof. Orla Morrissey (Department of Infectious Diseases) with sixty-five global experts have recently updated the definitions for invasive fungal disease which now become the new reference standard for clinical, epidemiological and diagnostic research.

Definitions of invasive fungal disease are critical for early diagnosis to guide early treatment and consequently improve survival rates. These definitions are also critical for unbiased clinical trials research and for epidemiological surveillance studies

Read more here

Dr Joseph Doyle has been honoured with a prestigious Australian Institute of Policy and Science (AIPS) Tall Poppy Award for his community engagement and leadership in the epidemiology, management and prevention of blood-borne viruses – HIV, hepatitis C and hepatitis B.

Dr Andrew Stewardson and Dr Orla Morrissey - contributors to the Diagnosis, management and prevention of Candida auris in hospitals - ASID position paper. -IMJ Editor's Choice -
 

We have a new superbug, and it’s time to take notice

The highly-drug resistant fungus, Candida auris was only discovered 10 years ago but is already causing serious problems in Healthcare facilities worldwide. The first case was identified in Victoria in 2018, which spurred leading infectious disease bodies to form a working party to tackle this growing problem.

Recently released is an important ‘position statement’ from Australian and New Zealand Mycoses Interest Group and the Hospital Infection special Interest Group from the Australasian Society for Infectious Diseases. Contributing authors, Dr Andrew Stewardson, and Dr Orla Morrissey are infectious diseases physicians in the Department of Infectious Diseases, the Alfred and Monash University.

Dr Joseph Doyle wins Club Melbourne Fellowship

 

The 2019 Club Melbourne Fellowship was awarded to Dr Joseph Doyle from the Burnet Institute, who received the $10,000 grant to support his attendance at an international conference of his choosing to enable new, life-changing opportunities for his research project.


Club Melbourne invests in the Fellowship with the hope that the Program’s Fellows will evolve to become Ambassadors themselves in the future.


Dr Joseph Doyle is a specialist in infectious diseases and public health medicine. He leads a clinical and implementation research program across the Burnet Institute, The Alfred, and Monash University with the aim to improve the access and delivery of hepatitis C treatment.


He is a leader of the Eliminate C Australia Partnership, which aims to build capacity and support for HCV elimination across all jurisdictions nationally. He has been an advisor and consultant to the World Health Organisation on HIV and Viral Hepatitis, and has received research support as a chief investigator from National Health & Medical Research Council, WHO, philanthropic organisations and industry.